Pfizer
PFE
2,864 hedge funds and large institutions have $92.7B invested in Pfizer in 2026 Q2 according to their latest regulatory filings, with 157 funds opening new positions, 1,171 increasing their positions, 1,232 reducing their positions, and 239 closing their positions.
47% more capital inflows, than outflows
Capital inflows: $7.48B | Capital outflows: $5.08B
1.35% more ownership
Funds ownership: 66.19% → 67.54% (+1.3%)
5% less repeat investments, than reductions
Existing positions increased: 1,171 | Existing positions reduced: 1,232
10% less call options, than puts
Call options by funds: $2.36B | Put options by funds: $2.62B
4% less funds holding
Funds holding: 2,981 → 2,864 (-117)
34% less first-time investments, than exits
New positions opened: 157 | Existing positions closed: 239
55% less funds holding in top 10
Funds holding in top 10: 47 → 21 (-26)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$823M |
| 2 |
BlackRock
New York
|
+$822M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$175M |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
+$168M |
| 5 |
Goldman Sachs
New York
|
+$154M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$578M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$400M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$276M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$251M |
| 5 |
Amundi
Paris,
France
|
-$191M |
PFE Hedge Fund Activity: Q2 2026 in Review
2,864 of the 8,401 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q2 2026, worth a combined $92.7B — down 12% from $106B a quarter earlier.
Sellers outnumbered buyers: 239 funds closed out of PFE and 157 opened new positions — a net loss of 82 holders — while 1,232 trimmed existing stakes and 1,171 added.
The largest buyer was Royal Bank of Canada, adding an estimated $823M. The largest seller was Wellington Management Group, cutting an estimated $578M.
- 2,864 institutional investors held Pfizer (PFE) as of Q2 2026, down from 2,981 in Q1 2026.
- Funds reported $92.7B of Pfizer stock for Q2 2026, down 12% quarter-over-quarter.
- 157 funds opened new Pfizer positions in Q2 2026 and 239 closed out, a net change of -82 holders.
- The largest Pfizer buyer in Q2 2026 was Royal Bank of Canada, an estimated $823M added.
- The largest Pfizer seller in Q2 2026 was Wellington Management Group, an estimated $578M sold.
Based on aggregated 13F filings for Q2 2026.